Chronic Obstructive Pulmonary Disease

A progressive, largely smoking-related obstructive lung disease encompassing chronic bronchitis and emphysema, managed with bronchodilators, inhaled corticosteroids, and, in advanced disease, biologics and oxygen therapy.

Phase 1/2 and later readouts in Chronic Obstructive Pulmonary Disease, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

Total attributable cost

$61.4B

$4,322/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities, diagnosed (2022 estimate) · US

All assets in Chronic Obstructive Pulmonary Disease

← Respiratory